Stay updated on SY-1425 Biomarker-Directed Trial in AML/MDS Clinical Trial
Sign up to get notified when there's something new on the SY-1425 Biomarker-Directed Trial in AML/MDS Clinical Trial page.

Latest updates to the SY-1425 Biomarker-Directed Trial in AML/MDS Clinical Trial page
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page now displays a 403 Forbidden error with a minimal header and a Home link, replacing the previous study record content and attached documents; users cannot view the study details.SummaryDifference20%

- Check23 days agoChange DetectedThe page's revision tag was updated from v3.6.6 to v3.7.0. This reflects an administrative update to the study record's version history rather than a change to study details or content.SummaryDifference0.0%

- Check37 days agoChange DetectedThe page’s revision label was updated from v3.6.5 to v3.6.6, indicating an internal update to the study page. The change does not alter the study details visible to users.SummaryDifference0.0%

- Check44 days agoChange DetectedA new line '2017 ( U.S. NIH Grant/Contract )' was added to the study identifiers, indicating NIH funding information associated with the trial.SummaryDifference0.0%

- Check58 days agoChange DetectedThe page's revision line now shows Revision: v3.6.5, replacing the previous v3.6.4, indicating a small update to the page's version history.SummaryDifference0.0%

- Check73 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4, indicating a small page update. This appears to be a minor patch with no substantive changes to the study content or user-facing information.SummaryDifference0.0%

Stay in the know with updates to SY-1425 Biomarker-Directed Trial in AML/MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SY-1425 Biomarker-Directed Trial in AML/MDS Clinical Trial page.